1344 ET - Constellation Brands' third-quarter volume miss fed into the rapidly growing alcohol negative that has emerged from media coverage of Dry January, Barclays analysts say in a research note. It also came after the U.S. Surgeon General called for cancer warnings on alcoholic beverages. "As such, Friday's print felt to us like a referendum on alcohol consumption," the analysts say on the maker of beer, wine and spirits' latest results. "We recognize it will be tough to change the tide in sentiment in the near term," the analysts say as they cut their EPS estimates for the reminder of fiscal 2025 and fiscal 2026. Still, the analysts believe Constellation Brands' algorithm in a slower growth environment still remains at compelling proposition at this valuation. Shares rise 3.2% to $187.66. (sabela.ojea@wsj.com; @sabelaojeaguix)
(END) Dow Jones Newswires
January 13, 2025 13:44 ET (18:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。